Crizotinib, an Effective Agent in ROS1-Rearranged Adenocarcinoma of Lungs: A Case Report

INTRODUCTION: ROS1 rearrangement has recently emerged as a new molecular subtype in non–small-cell lung cancer (NSCLC) and is predominantly found in lung adenocarcinoma compared with other oncogenes such as EGFR, KRAS, or ALK. It has been identified in only 1% to 2% of NSCLC cases. CASE REPORT: We r...

Descripción completa

Detalles Bibliográficos
Autores principales: Joshua, Julie Mariam, KD, Salima, K, Pavithran, Vijayan, Meenu
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2018
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5772496/
https://www.ncbi.nlm.nih.gov/pubmed/29371790
http://dx.doi.org/10.1177/1179547617749615

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5772496/
https://www.ncbi.nlm.nih.gov/pubmed/29371790
http://dx.doi.org/10.1177/1179547617749615

Ejemplares similares